Reply To: EAP from Open label studies
April 1, 2021 at 9:41 amAmy,
I saw your question in the forum and thought to reply for a variety of reasons. TrialCard is our company name and we work with clinical-stage companies from phase 1-phase 4, and launch a host of commercial drugs. We have the RxStudy Card service that allows for commercially available products to be managed by pharmacies, we have a non-commercial dispensing pharmacy in the USA that can manage EAP, allowing you to remain in communication and supportive of patients while waiting for BLA or PDUFA conclusion. Then once approved, we can assist the launch to these and greater patient populations. are you open to a chat?
Tom Heck
SVP Clinical Trial Services
919-415-3155
tom.heck@trailcard.com
